ESR1 and neoplasm: Tumour size, nodal status, the presence of distant metastases at diagnosis, tumour multifocality, ER or PR expression, Ki-67 expression, HER2 amplification, immunohistochemical synaptophysin or chromogranin expression, primary tumour size (in mm), or parity were not associated with the presence of any pathogenetic or unknown variants.